{"id":"https://openalex.org/W2008008752","doi":"https://doi.org/10.1358/dof.2005.030.12.949486","title":"Sitaxsentan: Update on basic science studies and clinical trials supporting selective endothelin ETA receptor antagonism in the treatment of pulmonary arterial hypertension","display_name":"Sitaxsentan: Update on basic science studies and clinical trials supporting selective endothelin ETA receptor antagonism in the treatment of pulmonary arterial hypertension","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2008008752","doi":"https://doi.org/10.1358/dof.2005.030.12.949486","mag":"2008008752"},"language":"en","primary_location":{"id":"doi:10.1358/dof.2005.030.12.949486","doi":"https://doi.org/10.1358/dof.2005.030.12.949486","is_oa":false,"landing_page_url":"https://doi.org/10.1358/dof.2005.030.12.949486","pdf_url":null,"source":{"id":"https://openalex.org/S154339661","display_name":"Drugs of the Future","issn_l":"0377-8282","issn":["0377-8282","2013-0368"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313017","host_organization_name":"Thomson Reuters","host_organization_lineage":["https://openalex.org/P4310313017"],"host_organization_lineage_names":["Thomson Reuters"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of the Future","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010300009","display_name":"Neil J. Davie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Davie, N.J.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Coyne, T.C.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Coyne, T.C.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5060164161","display_name":"Richard A. F. Dixon","orcid":"https://orcid.org/0000-0002-8138-7256","observed_orcids":["https://orcid.org/0000-0002-8138-7256"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dixon, R.","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2648,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.65701099,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"12","first_page":"1283","last_page":"1283"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12199","display_name":"Vascular Anomalies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13505","display_name":"Apelin-related biomedical research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sitaxsentan","display_name":"sitaxsentan","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pulmonary-arterial-hypertension","display_name":"pulmonary arterial hypertension","score":0.8949999809265137},{"id":"https://openalex.org/keywords/endothelin-receptor-antagonists","display_name":"endothelin receptor antagonists","score":0.9779999852180481},{"id":"https://openalex.org/keywords/pulmonary-vascular-remodeling","display_name":"pulmonary vascular remodeling","score":0.8690000176429749},{"id":"https://openalex.org/keywords/neointima-formation","display_name":"neointima formation","score":0.8069999814033508},{"id":"https://openalex.org/keywords/pulmonary-vascular-resistance","display_name":"pulmonary vascular resistance","score":0.6420000195503235},{"id":"https://openalex.org/keywords/right-heart-failure","display_name":"right heart failure","score":0.9490000009536743},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.8098322153091431},{"id":"https://openalex.org/C144980905","wikidata":"https://www.wikidata.org/wiki/Q24721308","display_name":"Endothelin receptor","level":3,"score":0.7398521900177002},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6213870048522949},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.563550591468811},{"id":"https://openalex.org/C2780930700","wikidata":"https://www.wikidata.org/wiki/Q1128595","display_name":"Pulmonary hypertension","level":2,"score":0.5009870529174805},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45765697956085205},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.38316065073013306},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34467238187789917},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2889855206012726}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1358/dof.2005.030.12.949486","doi":"https://doi.org/10.1358/dof.2005.030.12.949486","is_oa":false,"landing_page_url":"https://doi.org/10.1358/dof.2005.030.12.949486","pdf_url":null,"source":{"id":"https://openalex.org/S154339661","display_name":"Drugs of the Future","issn_l":"0377-8282","issn":["0377-8282","2013-0368"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4310313017","host_organization_name":"Thomson Reuters","host_organization_lineage":["https://openalex.org/P4310313017"],"host_organization_lineage_names":["Thomson Reuters"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drugs of the Future","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8500000238418579}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1973385981","https://openalex.org/W2280985989","https://openalex.org/W1955970211","https://openalex.org/W2127454578","https://openalex.org/W2109708551","https://openalex.org/W7098675900","https://openalex.org/W2028386926","https://openalex.org/W1532458526","https://openalex.org/W2014422086","https://openalex.org/W2009411008"],"abstract_inverted_index":{"Pulmonary":[0],"arterial":[1],"hypertension":[2],"(PAH)":[3],"is":[4,35],"a":[5,87],"rare":[6],"and":[7,21,45],"typically":[8],"progressive":[9],"condition":[10],"characterized":[11,36],"clinically":[12],"by":[13,38],"sustained":[14],"increases":[15],"in":[16,28,72],"mean":[17],"pulmonary":[18,22,51],"artery":[19],"pressure":[20],"vascular":[23,39],"resistance,":[24],"which":[25],"often":[26],"culminate":[27],"fatal":[29,93],"right":[30],"heart":[31],"failure.":[32],"The":[33,76],"disease":[34],"histopathologically":[37],"remodeling,":[40],"with":[41,57],"neointimal":[42],"formation,":[43],"fibrosis":[44],"vessel":[46],"wall":[47],"thickening":[48],"of":[49],"small":[50],"arteries.":[52],"Treatment":[53],"options":[54],"are":[55],"limited,":[56],"only":[58],"one":[59],"oral":[60],"endothelin":[61,79],"receptor":[62,83],"antagonist":[63,84],"(ETRA)":[64],"therapy":[65,89],"being":[66],"approved":[67],"to":[68],"date":[69],"for":[70,90],"use":[71],"the":[73],"United":[74],"States.":[75],"highly":[77],"selective":[78],"ET":[80],"A":[81],"sitaxsentan":[85],"represents":[86],"promising":[88],"this":[91],"frequently":[92],"condition.":[94]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}